Results have shown that the expression levels of CCL2 and VEGF-B in lung macrophages reduced after the treatment of BC-derived exosomes containing decreased Cav-1, while the expression level of CCL2 and VEGF-B increased in the high expression level of Cav-1 group (Figure 5H-J). The gene discussed is VEGFB; the disease is breast cancer.